NKF 2010 Hyperphosphatemia Coverage
LAS VEGAS—Fibroblast growth factor 23 (FGF-23) is not significantly associated with dietary phosphorus or urinary phosphorus excretion, researchers reported at the National Kidney Foundation's Spring Clinical Meetings.
Using sevelamer instead of calcium-based binders (CBBs) to treat hyperphosphatemia in dialysis patients can significantly decrease the number of days of hospitalization.
Sevelamer carbonate significantly decreases the bioavailability of oral calcitriol when the two drugs are administered together, but lanthanum carbonate does not, show data presented at the National Kidney Foundation's 2010 Spring Clinical Meetings.
The daily fluid intake with phosphate binder (PB) pills accounts for a significant portion of the daily fluid restriction in hemodialysis (HD) patients, suggest data presented at the National Kidney Foundation's 2010 Spring Clinical Meetings.
Higher serum phosphorus is associated with lower pulse pressure in women, but not men, with non-dialysis dependent CKD, according to researchers at the National Kidney Foundation's 2010 Spring Clinical Meetings.
Proton pump inhibitors (PPIs) taken concurrently with phosphate binders may increase phosphate control in hemodialysis (HD) patients, according to researchers who presented their data at the National Kidney Foundation's 2010 Spring Clinical Meetings..
Lanthanum carbonate rapidly reduces serum phosphorus levels in dialysis patients, according to an analysis of data from four clinical trials reported at the National Kidney Foundation's 2010 Spring Clinical Meetings.
Lanthanum carbonate provides sustained long-term reduction of serum phosphorus in dialysis patients, according to a study presented at the National Kidney Foundation 2010 Spring Clinical Meetings.
The phosphorus content of a typical American diet significantly increases levels of fibroblast growth factor-23 (FGF-23), a pilot study suggests.
ORLANDO, Fla.—Patients converted from in-center conventional hemodialysis (ICHD) to in-center nocturnal hemodialysis (NHD) have improvements in serum phosphorus levels and blood pressure (BP) control, according to two studies of the same cohort of 418 patients.
Renal and Urology News Articles
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)